ME Stock Price, Chart, Stats & News

23andMe Holding Co.
Save
15.31M
Market cap
–
Current P/E
–
Forward P/E
ME chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 53.33% |
Operating margin | -114.00% |
Pretax margin | -112.33% |
Net margin | -134.54% |
Effective tax rate | 3.49% |
ROA | -163.04% |
ROE | -552.02% |
D/E | 0.83x |
Interest coverage ratio | – |
ME valuation
P/E | – |
P/S | 0.09x |
P/B | 0.51x |
P/CF | -0.11x |
P/FCF | -0.10x |
P/OCF | -0.11x |
PEG | -0.00x |
EV multiple | -0.20x |
About
23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected via their proprietary kit. These reports offer insights into customers' genetic ancestral origins, predispositions to certain personal health risks, the likelihood of being a carrier for rare conditions that could be passed to offspring, and how their genetic makeup might influence responses to various medications.
Similar securities
Based on sector and market capitalization
Report issue











